About Us

Dr. Catherine Vaillant brings over 20 years of experience in drug discovery and biomarker development, with deep expertise in neuroscience, oncology, and immunology.

Based in Allschwil, Switzerland, she has led projects at the interface of preclinical biology and translational research, including 3D cell models, pharmacodynamic biomarkers, and mode-of-action studies.

With a proven track record in target validation, signal transduction, and complex assay systems, she offers strategic scientific support to biotech and pharma teams across early and mid-stage development.

Get in touch to explore how we can accelerate your next project.